Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Consolidated net (loss) income	$ (14,462)	$ 11,251
Adjustments to reconcile consolidated net (loss) income to net cash provided by operating activities:
Depreciation and amortization	4,614	4,199
Stock-based compensation expense	3,780	2,817
Litigation-contingency expense	17,200	0
(Decrease) increase in long-term deferred revenue	(360)	2,038
(Decrease) increase in other assets	(99)	33
Deferred income taxes	4	0
Increase in long-term income taxes payable	8	7
Change in current assets and liabilities, net	(8,103)	(10,232)
Net cash provided by operating activities	2,582	10,113
Investing activities:
Additions to property, plant and equipment and internal-use software	(7,270)	(10,089)
Net cash used for investing activities	(7,270)	(10,089)
Financing activities:
Proceeds from employee stock plans	1,756	2,261
Net cash provided by financing activities	1,756	2,261
Effect of foreign exchange rates on cash	(115)	1
Net (decrease) increase in cash and cash equivalents	(3,047)	2,286
Cash and cash equivalents at beginning of period	242,219	190,611
Cash and cash equivalents at end of period	239,172	192,897
Supplemental disclosure:
Purchases of property, plant and equipment and internal-use software incurred but not yet paid	$ 1,983	$ 2,083